Overview Financials News + Filings
|
|
Curative Biotechnology Inc
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 |
| | S-1/A | S-1/A |
| Revenues | 100.0% | 100.0% |
| Cost of goods sold | 16.6% | 3.0% |
| Gross profit | 83.4% | 97.0% |
| Research and development | 12.8% | |
| General and administrative | 68.9% | 95.5% |
| Depreciation | 0.1% | 0.1% |
| EBIT | -81.8% | -95.6% |
| Pre-tax income | -86.7% | -97.0% |
| Income taxes | 0.0% | 0.0% |
| Net income | -307.9% | -97.1% |
|